Sourav Ganguly files 50 crore lawsuit after being dragged into Lionel Messi Kolkata controversy

Moneycontrol
Sourav Ganguly is suing for 50 crore after being implicated in the chaos surrounding Lionel Messi's Kolkata visit.

Summary

Former India captain Sourav Ganguly has filed a 50 crore lawsuit following his alleged involvement in the controversy surrounding Lionel Messi’s visit to Kolkata’s Salt Lake Stadium. Reports indicate Ganguly was present at the stadium during Messi’s visit but was in a separate section when the chaos erupted. The lawsuit suggests Ganguly’s reputation was damaged by being associated with the incident. The article notes the date of reporting as December 19, 2025.

(Source:Moneycontrol)

WBRZ

$5M lawsuit claims Disney's California theme parks illegally collect facial recognition data

CP24 Toronto

Judge approves class action lawsuit launched by Quebec TV personality

The Bradenton Times

Maryland reaches $4.1M settlement with homebuilder in sediment pollution case

Tekedia

Tether Invests on LemFi to Accelerate Stablecoin Settlement Flow in Africa and Asia

Headtopics

President Trump, Family, and Businesses Shielded from Pending Tax Audits as Part of DOJ Settlement

Bitcoin News

Evernorth Highlights XRP’s ‘Actual Story’ Beyond JPMorgan Settlement Attention

Punch

SEC fixes June 1 for T+1 settlement cycle transition

Firstpost

Why is Trump’s new IRS settlement triggering allegations of ‘self-dealing’?

Syracuse Ny Local News

Government to permanently drop tax claims against Trump family as part of lawsuit settlement

USA TODAY

Disney sued over facial recognition at California theme parks

New York Post

Disneyland targeted in class-action lawsuit claiming new program is violating guests' privacy

Bangor Daily News

Journalists sue tech giants over 'stolen' voices for AI training

The Mercury News

Disneyland hit with $5 million lawsuit over use of facial recognition technology

Devdiscourse

UPDATE 4-Takeda engaged in antitrust scheme to delay generic constipation drug, US jury finds

The Japan Times

Takeda engaged in antitrust scheme to delay generic constipation drug: U.S. jury